Distinct populations of crypt-associated fibroblasts act as signaling hubs to control colon homeostasis
Michael David Brügger , Contributed equally to this work with: Michael David Brügger, Tomas Valenta, Hassan Fazilaty Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Software, Visualization, Writing – original draft, Writing – review & editing
Affiliation Department of Molecular Life Sciences, University of Zurich, Switzerland Roles Conceptualization, Funding acquisition, Investigation, Methodology, Supervision, Writing – review & editing Roles Conceptualization, Data curation, Formal analysis, Software, Visualization, Writing – review & editing
Affiliation Department of Molecular Life Sciences, University of Zurich, Switzerland
Affiliation Department
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Direct from Saliva PCR Test for COVID-19 Enables Fast, Low-Cost Results for High-Frequency Surveillance Testing at Colleges and Universities
December 10, 2020 GMT
CARLSBAD, Calif., Dec. 10, 2020 /PRNewswire/ Thermo Fisher Scientific announced today the availability of a new direct from saliva PCR test for COVID-19 to enable widespread, high-frequency surveillance testing. The Applied Biosystems TaqCheck SARS-CoV-2 Fast PCR Assay uses raw saliva samples and simplifies lab workflows using instruments that are widely available globally to deliver reliable data quickly.
ADVERTISEMENT
The company also introduced the Safe Campus Reopening Program to subsidize the cost of the test for U.S. colleges, universities and post-secondary institutions. Availability of this program coincides with recent guidance issued by the Centers for Disease Control and Prevention (CDC) that calls for expanded COVI
Search jobs Thermo Fisher Scientific Gains CE Mark Certification for New OmniPATH Combi SARS-CoV-2 IgG ELISA Test
Thermo Fisher Scientific, the world leader in serving science, has secured CE Mark certification for the Thermo Scientific OmniPATH Combi SARS-CoV-2 IgG ELISA test. The test is intended for the quantitative measurement of immunoglobulin G (IgG) antibodies raised against the spike protein of the SARS-CoV-2 virus to aid clinicians in identifying patients with an immune response pre- and post-vaccination.
The ability to quantify IgG is a critical component to understanding an individual’s immune response to the SARS-CoV-2 virus, especially as we start to vaccinate the population. Having quantitative data on neutralizing antibodies will enable better understanding of a person’s immune response following exposure to the COVID-19 virus and support monitoring of the effectiveness of vaccines as they become available.
Thermo Fisher to Expand in Greenville, Add 500 New Jobs
Thermo Fisher Scientific, a global life science services company with major operations in North Carolina, will add 500 new jobs in Greenville over the next two years as it expands its sterile drug product development and commercial manufacturing of critical medicines, therapies and vaccines.
The investment, approximately $500 million, will include a new, stand-alone, 130,000-square-foot facility with two live- virus filling lines that will be operational in 2022. The site will also add six new lines in 2021 and 2022, including commercial-scale liquid filling lines and a development line for liquid and lyophilized (freeze-dried) drug products.
by Barry Teater, NCBiotech Center December 10, 2020 .
RESEARCH TRIANGLE PARK – Thermo Fisher Scientific, a global life science services company with major operations in North Carolina, will add 500 new jobs in Greenville over the next two years as it expands its sterile drug product development and commercial manufacturing of critical medicines, therapies and vaccines.
The investment, approximately $500 million, will include a new, stand-alone, 130,000-square-foot facility with two live- virus filling lines that will be operational in 2022. The site will also add six new lines in 2021 and 2022, including commercial-scale liquid filling lines and a development line for liquid and lyophilized (freeze-dried) drug products.